PharmaShots Weekly Snapshot (February 01-05, 2021)
Reistone Report Results for SHR0302 in P-II Study to Treat Ulcerative Colitis
Published: Feb 5, 2020 | Tags: Reiston, Report, Result, SHR0302, P-II, Study, Treat, Ulcerative Colitis
Enzene Receives Marketing Authorization for Teriparatide (biosimilar) in India
Published: Feb 5, 2020 | Tags: Enzene, Receives, Marketing Authorization, Teriparatide (biosimilar), India
Johnson & Johnson Reports EUA Submission to US FDA's for its Single Shot COVID-19 Vaccine Candidate
Published: Feb 5, 2020 | Tags: Johnson & Johnson, Reports, EUA, Submission, US, FDA, Single Shot, COVID-19, Vaccine, Candidate
23andMe Going Public Via Virgin Group SPAC Merger
Published: Feb 5, 2020 | Tags: 23andMe, Going, Public, Virgin Group, SPAC, Merger
Published: Feb 5, 2020 | Tags: Biocon Biologics, Signs, Agreement, CHAI, Expand, Access, Oncology, Biosimilars, 30 Countries
AstraZeneca's Forxiga (dapagliflozin) Receives NMPA's Approval for Chronic Heart Failure
Published: Feb 5, 2020 | Tags: AstraZeneca, Forxiga (dapagliflozin), Receives, NMPA, Approval, Chronic, Heart Failure
Published: Feb 4, 2020 | Tags: Astellas, Xospata (gilteritinib), Receives, NMPA, Conditional, Approval, R/R AML, FLT3 Mutation
Daiichi Sankyo Initiates P-II Study of Patritumab Deruxtecan in Patients with EGFR-Mutated NSCLC
Published: Feb 4, 2020 | Tags: Daiichi Sankyo, Initiates, P-II, Study, Patritumab Deruxtecan, Patients, EGFR-Mutated NSCLC
Thermo Fisher Collaborates with JW Therapeutics for CAR-T Therapies in China
Published: Feb 4, 2020 | Tags: Thermo Fisher, Collaborates, JW Therapeutics, CAR-T Therapies, China
Published: Feb 4, 2020 | Tags: Pfizer, Signs, License, Research Agreement, Imcyse, Develop, Imotopes, Rheumatoid Arthritis
Published: Feb 4, 2020 | Tags: Merck KGaA, Tepmetko (tepotinib), Receives, US, FDA, Approval, Patients, Metastatic NSCLC, METex14, Skipping, Alterations
Jazz to Acquire GW Pharmaceuticals for $7.2B
Published: Feb 4, 2020 | Tags: Jazz, Acquire, GW Pharmaceuticals, $7.2B
Covaxx Initiates P-II Trial of UB-612 Against COVID-19 in Taiwan
Published: Feb 3, 2020 | Tags: Covaxx, Initiates, P-II, Trial, UB-612, Against, COVID-19, Taiwan
Russia's Sputnik V Demonstrates 92% Efficacy Against COVID-19
Published: Feb 3, 2020 | Tags: Russia, Sputnik V, Demonstrates, 92%, Efficacy, Against, COVID-19
GSK Collaborate with CureVac to Develop Next Generation mRNA COVID-19 Vaccines
Published: Feb 3, 2020 | Tags: GSK, Collaborate, CureVac, Develop, Next, Generation, mRNA COVID-19, Vaccines
Published: Feb 3, 2020 | Tags: Innovent, Tyvyt (sintilimab), Pemetrexed, Platinum CT, Receives, NMPA, Approval, 1L, Therapy, Non-squamous Non-Small Cell Lung Cancer
Genentech Signs an Exclusive License Agreement with X-Chem to Discover Oncology Targets
Published: Feb 3, 2020 | Tags: Genentech, Signs, Exclusive, License, Agreement, X-Chem, Discover Oncology, Targets
Published: Feb 3, 2020 | Tags: BMS, Deucravacitinib, Demonstrate, Superiority, Otezla (apremilast), P-III, POETYK PSO-2, Study, Plaque Psoriasis
Published: Feb 2, 2020 | Tags: Celltrion, Receives, Health, Canada, Approval, Remsima SC (biosimilar, infliximab), Rheumatoid Arthritis
Clover and Dynavax Plan to Initiate P-II/III Trial for Adjuvanted COVID-19 Vaccine Candidate
Published: Feb 2, 2020 | Tags: Clover, Dynavax, Plan, Initiate, P-II/III, Trial, Adjuvanted, COVID-19 Vaccine, Candidate
Published: Feb 2, 2020 | Tags: Medtronic, Receives, US, FDA, Approval, DiamondTemp, Ablation System, Treat, Atrial Fibrillation
Published: Feb 2, 2020 | Tags: Janssen, Reports, CHMP, Acceptance, Accelerated, Assessment, Cilta-cel, MAA, Treat, Patients, Heavily, Pretreated, Multiple Myeloma
Gilead Signs an Option and License Agreement with Gritstone for HIV Vaccine
Published: Feb 2, 2020 | Tags: Gilead, Signs, Option, License Agreement, Gritstone, HIV Vaccine
Horizon Therapeutics to Acquire Viela Bio for ~ $3.05B
Published: Feb 2, 2020 | Tags: Horizon, Therapeutics, Acquire, Viela Bio, ~ $3.05B
Incyte Receive Positive CHMP's Opinion for Pemigatinib
Published: Feb 1, 2020 | Tags: Incyte, Receive, Positive, CHMP, Opinion, Pemigatinib
Published: Feb 1, 2020 | Tags: Gan & Lee, Receives, US, FDA, Fast Track Designation, GLR2007 Treatment, Patients, Glioblastoma
Johnson & Johnson Report Results from P-III ENSEMBLE Trial for COVID-19 Vaccine
Published: Feb 1, 2020 | Tags: Johnson & Johnson, Report, Results, P-III, ENSEMBLE Trial, COVID-19 Vaccine
Published: Feb 1, 2020 | Tags: Amgen, Sotorasib, Receives, NMPA, Breakthrough Therapy Designation, China, Treatment, Advanced, NSCLC, KRAS G12C Mutation
Novo Nordisk Receives the CHMP's Positive Opinion for Sogroya (somapacitan)
Published: Feb 1, 2020 | Tags: Novo Nordisk, Receives, CHMP, Positive Opinion, Sogroya (somapacitan)
Published: Feb 1, 2020 | Tags: Merck, Report, Results, Keytruda (pembrolizumab), Combination, Ipilimumab, Keytruda Monotherapy, P-III, KEYNOTE-598, Metastatic, Non-Small Cell Lung Cancer Patients
Related Post: PharmaShots Weekly Snapshots (Jan 25- 29, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com